From Mechanism To Longevity

Introducing MOAT - the BIOIO platform

MOAT (mechanism of action technologies) is a MoA-driven clinical indication prediction engine. MOAT combines both experimental and computational approaches. The strengths of our approach are two-fold. First, ensuring an accurate understanding of a small molecule’s MoA is vital to establishing contexts in which it might be effective and what its side effect liabilities might be. Second, by ensuring the compounds we advance are bona fide gerotherapies, we ensures a ‘pipeline in a pill’ - where each asset can be used in multiple clinical indications. Both aspects of the MOAT platform ensure we are focused on drug efficacy, which is a main reason therapies fail.